O'Brien Greene & Co’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.4M | Sell |
29,635
-36
| -0.1% | -$12.8K | 2.95% | 12 |
|
|
2025
Q4 | $9.71M | Buy |
29,671
+85
| +0.3% | +$27K | 2.88% | 10 |
|
|
2025
Q3 | $8.35M | Sell |
29,586
-270
| -0.9% | -$78.3K | 2.57% | 14 |
|
|
2025
Q2 | $8.34M | Sell |
29,856
-1,018
| -3% | -$288K | 2.73% | 15 |
|
|
2025
Q1 | $9.62M | Sell |
30,874
-503
| -2% | -$149K | 3.23% | 8 |
|
|
2024
Q4 | $8.18M | Buy |
31,377
+73
| +0.2% | +$21.7K | 2.66% | 13 |
|
|
2024
Q3 | $10.1M | Sell |
31,304
-1,101
| -3% | -$360K | 3.14% | 4 |
|
|
2024
Q2 | $10.1M | Buy |
32,405
+3,248
| +11% | +$954K | 3.21% | 5 |
|
|
2024
Q1 | $8.29M | Sell |
29,157
-165
| -0.6% | -$48.3K | 2.73% | 10 |
|
|
2023
Q4 | $8.45M | Buy |
29,322
+1,224
| +4% | +$334K | 2.97% | 7 |
|
|
2023
Q3 | $7.55M | Buy |
28,098
+869
| +3% | +$217K | 2.76% | 10 |
|
|
2023
Q2 | $6.05M | Sell |
27,229
-279
| -1% | -$64.7K | 2.1% | 21 |
|
|
2023
Q1 | $6.65M | Buy |
27,508
+560
| +2% | +$137K | 2.49% | 12 |
|
|
2022
Q4 | $7.08M | Sell |
26,948
-51,307
| -66% | -$13.8M | 2.68% | 11 |
|
|
2022
Q3 | $17.6M | Buy |
78,255
+52,903
| +209% | +$12.8M | 2.34% | 13 |
|
|
2022
Q2 | $6.17M | Buy |
25,352
+305
| +1% | +$74.7K | 2.33% | 14 |
|
|
2022
Q1 | $6.06M | Buy |
25,047
+97
| +0.4% | +$22.3K | 2% | 18 |
|
|
2021
Q4 | $5.61M | Sell |
24,950
-13
| -0.1% | -$2.74K | 1.84% | 26 |
|
|
2021
Q3 | $5.31M | Buy |
24,963
+184
| +0.7% | +$42.4K | 1.94% | 24 |
|
|
2021
Q2 | $6.04M | Buy |
24,779
+534
| +2% | +$131K | 2.16% | 15 |
|
|
2021
Q1 | $6.03M | Sell |
24,245
-55
| -0.2% | -$13.1K | 2.39% | 13 |
|
|
2020
Q4 | $5.59M | Buy |
24,300
+130
| +0.5% | +$30K | 2.3% | 14 |
|
|
2020
Q3 | $6.14M | Sell |
24,170
-485
| -2% | -$120K | 2.92% | 7 |
|
|
2020
Q2 | $5.82M | Buy |
24,655
+115
| +0.5% | +$26.2K | 3.08% | 5 |
|
|
2020
Q1 | $4.97M | Sell |
24,540
-160
| -0.6% | -$34.9K | 3.31% | 7 |
|
|
2019
Q4 | $5.96M | Sell |
24,700
-475
| -2% | -$105K | 3.02% | 6 |
|
|
2019
Q3 | $4.87M | Buy |
25,175
+370
| +1% | +$71K | 2.61% | 9 |
|
|
2019
Q2 | $4.57M | Buy |
24,805
+387
| +2% | +$69.3K | 2.4% | 12 |
|
|
2019
Q1 | $4.64M | Buy |
24,418
+570
| +2% | +$109K | 2.34% | 11 |
|
|
2018
Q4 | $4.64M | Buy |
+23,848
| New | +$4.65M | 2.77% | 7 |
|
Other funds holding AMGN
VCM
VPM
O'Brien Greene & Co's AMGN Position: Q1 2026 in Review
O'Brien Greene & Co reduced its Amgen (AMGN) stake by 0.12% in Q1 2026, selling an estimated $12.8K and leaving 29,635 shares worth $10.4M. The position accounts for 2.95% of the portfolio, ranked #12.
O'Brien Greene & Co first reported a position in AMGN in Q4 2018 and has held it in 30 quarters since. The position peaked at $17.6M in Q3 2022. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- O'Brien Greene & Co held 29,635 shares of Amgen worth $10.4M as of Q1 2026.
- O'Brien Greene & Co sold 36 Amgen shares in Q1 2026, an estimated $12.8K.
- Amgen made up 2.95% of O'Brien Greene & Co's portfolio in Q1 2026, its #12 holding.
- O'Brien Greene & Co first reported a position in Amgen in Q4 2018 and has held it in 30 quarters since.
- O'Brien Greene & Co's Amgen position peaked at $17.6M in Q3 2022.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on O'Brien Greene & Co's 13F filing for Q1 2026, filed 6 May 2026.